1. Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?
   Tina W. Zhang et al, 2020, Current Treatment Options in Oncology CrossRef
2. Epid‐based in vivo dose verification for lung stereotactic treatments delivered with multiple breath‐hold segmented volumetric modulated arc therapy
   Savino Cilla et al, 2019, Journal of Applied Clinical Medical Physics CrossRef
3. An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines
   Lorna G. Keenan et al, 2018, Radiotherapy and Oncology CrossRef
4. Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study
   F. Deodato et al, 2023, Clinical Oncology CrossRef
5. Robotic Stereotactic Body Radiation Therapy in Patients With Recurrent or Metastatic Abdominopelvic Tumors
   D. Sezen et al, 2016, Technology in Cancer Research & Treatment CrossRef
6. MRI morphologic alterations after liver SBRT
   Judit Boda-Heggemann et al, 2016, Strahlentherapie und Onkologie CrossRef
7. Metastatic Breast Cancer: Prognosis, Diagnosis and Oncological Management
   Elżbieta Senkus et al, 2018, Breast Cancer Management for Surgeons CrossRef
8. Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis
   F. Deodato et al, 2022, Clinical and Translational Oncology CrossRef
9. The Role of Stereotactic Ablative Body Radiotherapy in Gynaecological Cancers: A Systematic Review
   L.C. Mendez et al, 2017, Clinical Oncology CrossRef
10. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups
    Gabriella Macchia et al, 2020, The Oncologist CrossRef
11. Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: a Pareto front analysis for liver metastases
    Savino Cilla et al, 2018, Medical Dosimetry CrossRef
12. Stereobody radiotherapy for nodal recurrences in oligometastatic patients: a pooled analysis from two phase I clinical trials
    Francesco Deodato et al, 2020, Clinical & Experimental Metastasis CrossRef
13. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters
    Hendrick Tan et al, 2021, Radiotherapy and Oncology CrossRef
14. Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial
    Francesco Deodato et al, 2019, The British Journal of Radiology CrossRef
15. Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis
    Cem Onal et al, 2020, International Journal of Gynecologic Cancer CrossRef